Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Mind Medicine Inc (MMED.NE)
Mind Medicine Inc (MMED.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mind Medicine Inc One World Trade Center Suite 8500 New York NY 10007 USA

P: 650-208-2454

Description:

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.

Key Statistics

Overview:

Market Capitalization, $K 211,691
Shares Outstanding, K 39,717
Annual Sales, $ 0 K
Annual Net Income, $ -56,796 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -29,130 K
60-Month Beta 3.54
% of Institutional Shareholders 5.12%

Growth:

1-Year Return -41.76%
3-Year Return -65.18%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -1.99
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 08/29/22

MMED.NE Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -65.37%
Return-on-Assets % -54.52%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity N/A
Price/Sales N/A
Price/Book 1.49
Book Value/Share 3.59
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar